SAN MATEO, Calif., Oct. 8, 2024 /PRNewswire/ — Selonterra, Inc. (www.selonterra.com), a biotechnology company developing transformative therapies for neurodegenerative disorders announces a second grant award of US$2,500,000 from The Michael J. Fox Foundation for Parkinson’s Research…
